Company / Gross Profit per Share
IMMUCELL CORP /DE/ Gross Profit per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.88
FY2025
5-year range
$0.50 / $2.05
FY2021-FY2025
Trend
+77.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share returned to growth in FY2025 after 3 years of decline, reaching $0.88.
Based on SEC 10-K filings.
0.88 in FY2025 with a 10-year CAGR of -1.1%.
Declined from $0.99 to $0.88 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -1.1%
Key checks
Key Insights
- In FY2025, gross profit per share increased 77.2% year-over-year.
- Peak gross profit per share was recorded in FY2016.
- Lowest gross profit per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.88 | +77.2% |
| FY2024 | $0.50 | -49.4% |
| FY2023 | $0.99 | -11.7% |
| FY2017 | $1.12 | -45.3% |
| FY2016 | $2.05 | +106.2% |
| FY2015 | $0.99 | +1.0% |
| FY2014 | $0.98 | +4.2% |
| FY2013 | $0.94 | +21.6% |
| FY2012 | $0.78 | -4.4% |
| FY2011 | $0.81 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026